Insmed Cash received from option exercises decreased by 12.5% to $30.31M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.1%, from $29.70M to $30.31M. Over 4 years (FY 2021 to FY 2025), Cash received from option exercises shows an upward trend with a 57.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher proceeds indicate active participation in equity incentive plans, which can signal employee confidence in the company's future stock performance.
Cash received by the company from employees or directors exercising their vested stock options. This reflects the liquid...
Common in companies with significant stock-based compensation; varies based on stock price performance relative to exercise prices.
other_proceeds_from_stock_options_exercised| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.57M | $2.49M | $6.02M | $6.82M | $6.45M | $4.07M | $2.17M | $1.14M | $7.28M | $2.34M | $7.64M | $4.05M | $68.57M | $26.88M | $13.74M | $29.70M | $36.97M | $34.41M | $34.64M | $30.31M |
| QoQ Change | — | -62.0% | +141.2% | +13.3% | -5.5% | -36.9% | -46.6% | -47.5% | +539.4% | -67.9% | +226.2% | -46.9% | >999% | -60.8% | -48.9% | +116.2% | +24.4% | -6.9% | +0.6% | -12.5% |
| YoY Change | — | — | — | — | -1.8% | +63.2% | -63.9% | -83.3% | +13.0% | -42.5% | +251.7% | +255.8% | +841.5% | >999% | +79.9% | +633.1% | -46.1% | +28.0% | +152.1% | +2.1% |